Amgen (AMGN) offers market-beating returns, a strong drug pipeline, and value at 15.1x forward P/E plus a 3% yield.
Gen Alpha is an Analyst at Seeking Alpha. With over 14 years of investment experience and an MBA in Finance, Gen specializes in defensive stocks and provides high-yield, dividend growth investment ideas, focusing on portfolio diversification and inflation hedging. Gen is featured in Seeking Alpha, where insights on finance, investment strategies, and asset management are shared.












